A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT05886491 · TERMINATED
Trial details
- NCT number
- NCT05886491
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-11
- Primary completion
- 2025-08-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.